茵栀黄口服液、丹参注射液联合蓝光照射治疗新生儿ABO溶血性黄疸的临床疗效分析

发布时间：2018-04-17 07:31

本文选题：茵栀黄口服液 + 丹参注射液　；参考：《中华中医药学刊》2017年06期

【摘要】：目的:探究茵栀黄口服液、丹参注射液联合蓝光照射治疗新生儿ABO溶血性黄疸的疗效与安全性。方法:将2013年9月—2016年9月的116例产科足月分娩(孕周≥37周)的ABO溶血性黄疸新生儿随机分成治疗组与对照组,治疗组采用茵栀黄口服液、丹参注射液联合蓝光照射治疗,对照组采用蓝光照射治疗,比较两组的疗效、血清胆红素水平变化以及不良反应等。结果:治疗组和对照组治疗的总有效率分别为98.28%和87.93%,治疗组明显的高于对照组,比较差异具有显著性(P0.05);治疗后1、3、5 d时治疗组患儿血清总胆红素明显的低于对照组,比较差异具有显著性(P0.05)。结论:茵栀黄口服液、丹参注射液联合蓝光治疗提高了新生儿ABO溶血性黄疸的治疗总有效率,促进了黄疸症状恢复,缩短了住院时间,安全性高。
[Abstract]:Objective: to explore the efficacy and safety of Yinzhihuang oral liquid, salvia miltiorrhiza injection combined with blue light irradiation in the treatment of neonatal ABO hemolytic jaundice.Methods: from September 2013 to September 2016, 116 neonates with ABO hemolytic jaundice were randomly divided into treatment group and control group. The treatment group was treated with Yinzhihuang oral liquid, salvia miltiorrhiza injection combined with blue light irradiation.The control group was treated with blue light irradiation. The curative effect, serum bilirubin level and adverse reaction were compared between the two groups.Results: the total effective rates of treatment group and control group were 98.28% and 87.93%, respectively, which were significantly higher in the treatment group than in the control group (P 0.05), and the serum total bilirubin in the treatment group was significantly lower than that in the control group at the 5th day after treatment.The difference was significant (P 0.05).Conclusion: Yinzhihuang oral liquid, salvia miltiorrhiza injection combined with blue light therapy can improve the total effective rate of neonatal ABO hemolytic jaundice, promote the recovery of jaundice symptoms, shorten the hospitalization time, and have high safety.
【作者单位】：宁波大学医学院附属医院儿科;
【基金】：宁波市科技局基金项目(2014C50090)
【分类号】：R722.17

【相似文献】